Clinical Trial 41482


Evanston, IL 60201

Study Summary:

Do you have acute migraines?
If so, you may qualify for a randomized, double-blind, single-dose, placebo-controlled study to assess the efficacy and safety of an investigational medication  for the acute treatment of migraine in adults with inadequate response to prior acute treatments.


Qualified Participants Must:

• Be male or female ages 18 to 65
• Have a history of episodic migraine for at least 1 year
• Have 2 to 8 migraine attacks per month
• Have had inadequate response to prior acute treatments

Qualified Participants May Receive:

Compensation for time and travel. 

Study is Available At:

Evanston Premier Healthcare Research
2500 RIdge Ave suite 109
Evanston, IL 60201
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 25 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.